Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment

Ann Intern Med. 1986 Feb;104(2):234-40. doi: 10.7326/0003-4819-104-2-234.

Abstract

Between 1 January 1981 and 1 December 1984, 34 of 396 patients with the acquired immunodeficiency syndrome (AIDS) developed cryptococcal infections. Twenty-six cases are reviewed. Twenty-two patients had brain or meningeal disease; the others had pulmonary disease (2 patients), pericarditis (1 patient), and antigenemia (1 patient). During treatment, 3 patients died of cryptococcosis and 3 died of other causes. Fifteen patients were followed for more than 6 weeks after treatment. Of 8 patients who received no additional amphotericin B, 4 had relapses and died of cryptococcosis within 6 months, 3 died of other causes, and 1 survived. Of 7 patients who received maintenance therapy with amphotericin B, none had relapses, 3 died of other causes, and 4 survived. Our data suggest that maintenance therapy with amphotericin may be needed to prevent relapse in patients with AIDS.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Amphotericin B / therapeutic use*
  • Brain Diseases / cerebrospinal fluid
  • Brain Diseases / diagnostic imaging
  • Brain Diseases / etiology
  • Cryptococcosis / diagnosis
  • Cryptococcosis / etiology
  • Cryptococcosis / mortality
  • Cryptococcosis / therapy*
  • Drug Therapy, Combination
  • Female
  • Flucytosine / therapeutic use
  • Humans
  • Injections, Intravenous
  • Injections, Intraventricular
  • Male
  • Meningitis / cerebrospinal fluid
  • Meningitis / etiology
  • Middle Aged
  • Prognosis
  • Recurrence
  • Retrospective Studies
  • Tomography, X-Ray Computed

Substances

  • Amphotericin B
  • Flucytosine